Control programme for antibiotic-resistant pneumococci; mandatory notification sometimes neglected by physicians;Läkare förbiser ibland anmälningsplikten

Lakartidningen

Volumn , Issue 51-52, 1997, Pages 4914-4918

  Hedlund, Jonas ^a,c   Olsson Liljequist, Barbro ^b  

^a Infektionskliniken   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFECTION CONTROL; PENICILLIN RESISTANCE; QUESTIONNAIRE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

DISEASE NOTIFICATION; HUMANS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; QUESTIONNAIRES; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 0031576573     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-5.
2. Bruyn GAW, Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis 1991; 10: 897-910.
3. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
4. Hansman D, Andrews G. A resistant pneumococcus. Lancet 1967; 2: 264-5.
5. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiple resistant pneumococci. N Engl J Med 1978; 299: 735-40.
6. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995; 171: 890-6.
7. Kristinsson KG, Hjdlmarsdóttir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992; 339: 1606-7.
8. Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-6.
9. Olsson-Liljequist B, Kahlmeter G. Antibiotikaresistens. Reellt hot även i Sverige. Lakartidningen 1997; 94: 115-7.
10. Kalin M. Bacteremic pneumococcal pneumonia: Value of nasopharynx culture and examination of washed sputum specimens. Eur J Clin Microbiol 1982; 1: 394-6.
11. Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 1987; 19: 491-502.
12. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995; 14: 879-84.
13. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33: 2759-62.
14. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983; 148: 131-7.
15. Scott JAG, Hall AJ, Dagan R, Dixon JMS, Eykyn SJ, Fenoll A et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7 000 episodes of invasive disease. Clin Infect Dis 1996; 22: 973-81.
16. Pneumokocker med nedsatt känslighet for penicillin. Bakgrund med analys av situationen i Sverige 1995. Stockholm: Socialstyrelsen, 1997. Expertrapport.
17. Ekdahl K, Hansson HBH, Melander E, Mölstad S, Persson K, Söderström M. Erfarenheter från sydsvenska pneumokockinterventionsprojektet [sammanfattning]. Svenska Läkaresällskapets handlingar Hygiea 1996; 105(1): 203.